Literature DB >> 22493037

Avoidable sight loss from glaucoma: is it unavoidable?

Aachal Kotecha1, Sofia Fernandes, Catey Bunce, Wendy A Franks.   

Abstract

AIMS: To review the characteristics of patients attending a tertiary ophthalmic referral centre certified as sight impaired (SI) or severely sight impaired (SSI) from glaucoma.
METHODS: One hundred consecutive patients certified SI/SSI from the Glaucoma Service at Moorfields Eye Hospital, London, from January 2007 were identified from the England and Wales certification of visual impairment database. Clinical and demographic data were collected from hospital case records.
RESULTS: The median (IQR) age of patients at presentation was 66.3 (55.6 to 75.3) years; median (IQR) interval to certification was 62.2 (22.5 to 129.3) months. Fifty-seven patients presented with bilateral SSI (median (IQR) age 70.4 (59.0 to 76.9) years); interval to certification was 35.4 (5.6 to 78.1) months. Seventeen patients presented with a bilateral SI (median (IQR) age 62.1 (58.7 to 68.4) years; median (IQR) interval to certification: 137.4 (64.4 to 190.4) months). Twenty-eight patients showed disease progression while under National Health Service hospital eye service care, five of whom had no certifiable visual impairment in either eye at presentation. This was attributed to inadequate intraocular pressure control; five of these patients (18%) were deemed poorly compliant to topical hypotensive medication.
CONCLUSIONS: Over 80% patients on the certification of visual impairment register from Moorfields Eye Hospital with glaucoma as the primary cause had a significant visual disability at presentation, with almost two-thirds of patients presenting bilaterally 'blind'. There appear to be delays to certification. Despite being under the hospital eye service, a number of glaucoma patients still progress to certifiable visual impairment.

Entities:  

Mesh:

Year:  2012        PMID: 22493037     DOI: 10.1136/bjophthalmol-2012-301499

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  9 in total

1.  What rates of glaucoma progression are clinically significant?

Authors:  Luke J Saunders; Felipe A Medeiros; Robert N Weinreb; Linda M Zangwill
Journal:  Expert Rev Ophthalmol       Date:  2016-05-13

Review 2.  Adaptive optics retinal imaging--clinical opportunities and challenges.

Authors:  Joseph Carroll; David B Kay; Drew Scoles; Alfredo Dubra; Marco Lombardo
Journal:  Curr Eye Res       Date:  2013-04-26       Impact factor: 2.424

Review 3.  Adaptive optics technology for high-resolution retinal imaging.

Authors:  Marco Lombardo; Sebastiano Serrao; Nicholas Devaney; Mariacristina Parravano; Giuseppe Lombardo
Journal:  Sensors (Basel)       Date:  2012-12-27       Impact factor: 3.576

4.  Patient satisfaction with glaucoma therapy: reality or myth?

Authors:  Hans G Lemij; Juliette Gmm Hoevenaars; Cees van der Windt; Christophe Baudouin
Journal:  Clin Ophthalmol       Date:  2015-05-04

5.  A study to assess the feasibility of undertaking a randomized controlled trial of adherence with eye drops in glaucoma patients.

Authors:  Cliff Richardson; Lisa Brunton; Nicola Olleveant; David B Henson; Mark Pilling; Jane Mottershead; Cecilia H Fenerty; Anne Fiona Spencer; Heather Waterman
Journal:  Patient Prefer Adherence       Date:  2013-10-07       Impact factor: 2.711

6.  Certification for vision impairment: researching perceptions, processes and practicalities in health and social care professionals and patients.

Authors:  T Boyce; Shaun Leamon; J Slade; P Simkiss; S Rughani; Faruque Ghanchi
Journal:  BMJ Open       Date:  2014-04-08       Impact factor: 2.692

7.  Medication adherence, self-efficacy and health literacy among patients with glaucoma: a mixed-methods study protocol.

Authors:  Maria Achilleos; Anastasios Merkouris; Andreas Charalambous; Evridiki Papastavrou
Journal:  BMJ Open       Date:  2021-01-20       Impact factor: 2.692

8.  Progression to severe visual impairment and blindness in POAG patients: pace and risk factors-a cohort study using German health claims data.

Authors:  Sophia Nestler; Daniel Kreft; Gabriele Doblhammer; Rudolf F Guthoff; Stefanie Frech
Journal:  BMJ Open Ophthalmol       Date:  2022-01-31

9.  Duplication of TBK1 Stimulates Autophagy in iPSC-derived Retinal Cells from a Patient with Normal Tension Glaucoma.

Authors:  Budd A Tucker; Frances Solivan-Timpe; Ben R Roos; Kristin R Anfinson; Alan L Robin; Luke A Wiley; Robert F Mullins; John H Fingert
Journal:  J Stem Cell Res Ther       Date:  2014-01-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.